New Tag-lite™ Cellular Platform for Cell Surface Receptor Study and Screening
11 May 2009
Learn about the new homogeneous, non-radioactive and cost-effective alternative for the study of cell surface receptor dimerization and ligand binding, two important investigation avenues in drug discovery research. SelectScience.tv interview with Cisbio Bioassays at SBS Annual Conference 09.
About the company
Cisbio Bioassays
Cisbio Bioassays is a privately held life sciences company committed to improving human healthcare. With more than 30 years of experience in in vitro diagnostics and drug discovery, we provide creative technological solutions and partnerships to the global scientific community. Our portfolio of over 460 proprietary assays and reagents is used by pharmaceutical, biotechnology, academia and contract research organizations worldwide to help generate effective therapies.
